Nilotinib-Induced Keratosis Pilaris by Wai Mun Sean Leong, Chen Wee Derrick Aw

Subjects: “…Bcr-Abl tyrosine kinase inhibitors…”
Get full text

Tip60-mediated acetylation activates transcription independent apoptotic activity of Abl by Pandita Tej K, Balasubramani Manimalha, Jin Shunquian, Kamath Ravindra, Jiang Zhihua, Rajasekaran Baskaran

Subjects: Get full text

c-Abl Deficiency Provides Synaptic Resiliency Against Aβ-Oligomers by Daniela A. Gutierrez, Lina M. Vargas, América Chandia-Cristi, Catalina de la Fuente, Nancy Leal, Alejandra R. Alvarez

Subjects: Get full text

Growth Factor Dependent Regulation of Centrosome Function and Genomic Instability by HuR by Natalia Filippova, Xiuhua Yang, Louis Burt Nabors

Subjects: “…ABL tyrosine kinase…”
Get full text

Multiple Keratoacanthomas, Philadelphia Chromosome+ Acute Lymphoblastic Leukemia, and Dasatinib: A Case Report by Siddhant Thukral, Lloyd E. King Jr, Lloyd E. King Jr, David H. Horowitz

Subjects: Get full text

The Risk of Arterial Thrombosis in Patients With Chronic Myeloid Leukemia Treated With Second and Third Generation BCR-ABL Tyrosine Kinase Inhibitors May Be Explained by Their Impa... by Hélène Haguet, Céline Bouvy, Anne-Sophie Delvigne, Elise Modaffari, Adeline Wannez, Pierre Sonveaux, Jean-Michel Dogné, Jonathan Douxfils, Jonathan Douxfils

Subjects: “…BCR-ABL tyrosine kinase inhibitor…”
Get full text

Design, synthesis, and biological evaluation of novel bromo-pyrimidine analogues as tyrosine kinase inhibitors by Chandrashekar S. Munikrishnappa, G.V. Suresh Kumar, Richie R. Bhandare, Afzal B. Shaik

Subjects: Get full text

BmAbl1 Regulates Silk Protein Synthesis via Glutathione Metabolism in <i>Bombyx mori</i> by Sheng Qin, Lingling Sun, Shu Zhang, Xia Sun, Muwang Li

Subjects: Get full text

Abl Tyrosine Kinase Regulates Hepatitis C Virus Entry by Saehong Min, Saehong Min, Yun-Sook Lim, Dongjo Shin, Dongjo Shin, Chorong Park, Chorong Park, Jae-Bong Park, Seungtaek Kim, Marc P. Windisch, Soon B. Hwang, Soon B. Hwang

Subjects: Get full text

Therapeutic strategy for chronic myeloid leukemia: possibilities and prospects by A G Turkina, E Iu Chelysheva

Subjects: Get full text

OCT-Based Management of Nilotinib-Associated CAD in a Patient With Chronic Myeloid Leukemia by Hiroyuki Kiriyama, MD, Junichi Ishida, MD, Hiroshi Kadowaki, MD, Takeshi Iwasa, MD, Arihiro Kiyosue, MD, Satoshi Kodera, MD, Jiro Ando, MD, Hiroshi Akazawa, MD, Issei Komuro, MD

Subjects: “…bcr-abl tyrosine kinase inhibitor…”
Get full text

Adverse Reaction Profiles Related to Gastrointestinal Bleeding Events Associated with BCR-ABL Tyrosine Kinase Inhibitors by Kei Kawada, Tomoaki Ishida, Kohei Jobu, Shumpei Morisawa, Naohisa Tamura, Shouhei Sugimoto, Masafumi Okazaki, Saburo Yoshioka, Mitsuhiko Miyamura

Subjects: Get full text

A generative neural network based on a hetero-encoder model for de novo design of potential anticancer drugs: application to Bcr-Abl tyrosine kinase by A. D. Karpenko, T. D. Vaitko, A. V. Tuzikov, A. M. Andrianov

Subjects: Get full text

Serum albumin and α-1 acid glycoprotein impede the killing of Schistosoma mansoni by the tyrosine kinase inhibitor Imatinib by Svenja Beckmann, Thavy Long, Christina Scheld, Rudolf Geyer, Conor R. Caffrey, Christoph G. Grevelding

Subjects: Get full text